Develops implants for opioid and alcohol addiction treatment.
Jun 2026Revenue $787K/yrExpenses $5.69M/yr
No trend
Figures by year
When will BioCorRx be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $787K and expenses $5.69M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $797K | $5.63M | −$4.83M |
| Dec 2024 | $7.67K | $5.13M | −$5.12M |
| Dec 2023 | $89.2K | $3.88M | −$3.79M |
| Dec 2022 | $214K | $4.91M | −$4.70M |
| Dec 2021 | $48.3K | $5.56M | −$5.51M |
| Dec 2020 | $123K | $7.61M | −$7.49M |
| Dec 2019 | $240K | $5.80M | −$5.56M |
| Dec 2018 | $377K | $5.00M | −$4.63M |
| Dec 2017 | $657K | $3.55M | −$2.89M |
| Dec 2016 | $702K | $2.88M | −$2.18M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.